Category: Weight Loss Products

As per the latest study by Persistence Market Research (PMR), the global weight loss dietary supplements market is anticipated to witness healthy growth. The market is likely to register 6.0% CAGR throughout the forecast period 2017-2026. The global weight loss dietary supplements market is also estimated to bring in US$ 37,177.6 million revenue by 2026 end.

With obesity becoming a global health concern, weight loss continues to be one of the most focused areas. Hence, increasing number of companies are coming up with the new products in weight loss supplements. The increasing consumption and demand for weight loss dietary supplements, regulations on the production of these supplements along with ingredients used are also gaining traction in various countries. The government in various countries are also focusing on the quality and quantity of ingredients used and if any of these ingredients can have severe side-effects, affecting the health of the consumers negatively.

Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/20380 

Increasing use of Natural and Organic Ingredients in the Weight Loss Dietary Supplements

The negative effects of being obese and overweight are resulting in the increasing use of weight management products. Consumers are also adopting weight loss supplements in forms of pill, liquid, and powder. Hence, with the increase in the use of these supplements, manufacturers are also trying to produce safer products, thereby using organic and natural ingredients and plant-based ingredients. Among various ingredients, green tea extract is considered as one of the most popular and safest ingredients in the weight loss dietary supplements. Similarly, Garcinia cambogia is also being considered as an ingredient in the weight loss supplements. However, these ingredients have been reported to have adverse effects like a headache, constipation, UTI. Hence, there has been an increase in the investment in the research on other organic ingredients that can be used to produce weight loss supplements.

Global Weight Loss Dietary Supplements Market: Segmental Insights

The global weight loss dietary supplements market includes various segments such as end-user, form, ingredients, distribution channel, and region. Based on the form, the market is categorized into powder, liquid, and soft gell/pills. Soft gell/pills are expected to dominate the market during the forecast period. By the end of 2026, soft gell/pills are expected to exceed US$ 18,500 million revenue.

Based on the end-user, the segment consists of men, women and senior citizen. Among these, women are expected to be the largest users of weight loss dietary supplements. Women segment as the end-user is estimated to create an incremental opportunity of more than US$ 7,900 million between 2017 and 2026.

By Distribution Channel, pharmacies drug store is expected to emerge as the largest distribution channel for the weight loss dietary supplements. Pharmacies drug store is estimated to account for more than one-third of the revenue share by the end of 2017.

Based on the ingredients, the segment consists of amino acids, vitamins minerals, botanical supplements, and others. Vitamins minerals are expected to emerge as one of the largest used ingredients in the weight loss dietary supplements. By the end of 2026, vitamins minerals are estimated to exceed US$ 16,900 million revenue.

Region-wise, the market is categorized into Europe, North America, Asia Pacific Excluding Japan (APEJ), Latin America, Japan, and the Middle East and Africa (MEA). Among the given regions, North America is expected to dominate the global weight loss dietary supplements market throughout the forecast period 2017-2026.

Access Report with Table of Contents @ https://www.persistencemarketresearch.com/methodology/20380 

Global Weight Loss Dietary Supplements Market: Competitive Assessment

Key players in the global weight loss dietary supplements market are Amway (Nutrilite), Abott Laboratories, GlaxoSmithKline, Glanbia, Herbalife International, Pfizer, American Health, Stepan, Nature’s Sunshine Products, and FANCL.

MONTREAL, July 30, 2018 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) and (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce it has received final listing approval for its Bioganix® Gold Series Nutraceuticals on Walmart.com and the products are currently live and available for purchase.

Relevium received today the final product listing approvals by the quality control team at Walmart.com and has begun selling its Bioganix® Gold Series nutraceutical products. As initially announced on May 3, 2018  the Company had received brand approval from Walmart.com to sell in its marketplace and today the Company received final approval for its initial product listing, which are currently live and available for purchase in the United States.

Bioganix® Gold Series is a unique and exclusive line of nutraceutical supplements designed exclusively for discerning health and wellness Walmart.com shoppers. The Company has launched an initial four (4) SKUs comprised of exclusive formulations from some of the highest volume sellers in the  Bioganix® product line. The company’s Bioganix Gold Series products includes; Apple Cider Vinegar Capsules, BioPro Advanced Probiotic, Garcinia Cambogia and Pure Forskolin.

Aurelio Useche, CEO of  Relevium stated: “The BioGanix® Gold Series is an exclusive Walmart.com line of nutraceuticals and supplements that gives the Company access to a new consumer base” Mr. Useche continued: “Our expectations for the new brand and the Walmart.com channel are high and we believe we will be able to scale the business and expand our available SKUs considerably faster than through our traditional distribution channels”  

Abis Hussain, CMO of  Relevium, stated: “In the coming months we will establish a working relationship with Walmart as we market our initial batch of products. Depending on demand, available traffic, conversion rates and ultimately profit margins, we will quickly move to launching additional exclusive products to Walmart.com through our Bioganix® Gold Series Nutraceutical brand”

Shareholders should expect updates on the initial performance Walmart.com in Q2 of this fiscal year.

About Relevium Technologies

Relevium is a TSXV-listed company focused on growth through the acquisition of businesses, products and/or brands with a focus on e-commerce in the growing health and wellness sector. The Company, through its wholly-owned subsidiary, Biocannabix Health Corporation, is also incorporating cannabinoids into its nutraceutical strategy and provide its retail customers access to the health benefits of cannabis through its formulations and established brands.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will be able to apply for and ultimately obtain an ACMPR licence, the proposed business of Biocannabix will develop as anticipated, that the Company will raise sufficient funds to develop the Biocannabix business, and that the Company will obtain all requisite regulatory approvals. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed business developments may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.

On Behalf of the Board of Directors

RELEVIUM TECHNOLOGIES INC.

Aurelio Useche
President and CEO

For more information about this press release:

Tel: +1.888.528.8687

RELEVIUM TECHNOLOGIES INC
Email: investors@releviumcorp.com
Website: www.releviumtechnologies.com
Like us on Facebook
Follow us on Twitter
Follow us on LinkedIn

In April 2018, ASCI’s Consumer Complaints Council (CCC) upheld complaints against 89 advertisements out of the total of 162 advertisements that were evaluated by the CCC.

Out of the total 89 advertisements against which complaints were upheld, 24 belonged to the healthcare sector, 34 to the education sector, 20 to the food beverages category, two to the personal care and nine were from the ‘others’ category. A total of 101 advertisements were picked up by ASCI’s suo moto surveillance, wherein 31 cases were informally resolved as advertisements were voluntarily withdrawn and objections against 68 advertisements were upheld. Of the 61 advertisements complained against by the general public or by industry members, 12 cases were informally resolved wherein the advertisements were voluntarily withdrawn and complaints against 21 advertisements were upheld by the CCC.

ALSO READ: ASCI Update: Complaints against 232 out of 305 ads are upheld

Exaggeration of product efficacy was the number one reason for upholding complaints. The other reasons included providing facts and figures which were inadequate to substantiate claims, exploiting consumers’ lack of knowledge, claims which were misleading by gross exaggeration and delivering advertisements which were misleading by ambiguity or by implication. This was followed by violations of the Drugs and Magic Remedies Act (DMR Act) and the Drugs and Cosmetics (DC) Rules and advertisements which contravened various ASCI guidelines.

Among the various complaints against advertisements, the CCC observed that a popular smartphone company was found to unethically attract customers by claiming the biggest sale ever in the history of India. Several advertisements used logos of AYUSH or FSSAI in their communication which was considered to be inappropriate as all AYUSH products in the market are required to have approval from the State Licensing authorities and calling it out separately as a claim, is misleading by implication that Ministry of AYUSH or FSSAI has approved the product efficacy/ claims made in the advertisement.

Shweta Purandare

“ASCI’s work in monitoring Print and TV advertisements for the AYUSH sector has also been recognized by the Parliamentary Standing Committee on Health Family Welfare. The committee was of the view that collaborative efforts of the ministry, along with the DoCA, MIB and State Governments, have certainly given results as misleading advertisements, with respect to AYUSH drugs, which have been unregulated so far, have been controlled to an extent. ASCI’s inclusion in the AYUSH’s empowered committee earlier this year is a reflection of regulators’ recognition of ASCI’s consistent efforts to curb misleading advertisements” says Shweta Purandare, secretary general of ASCI.

A total of 24 advertisements were complained against in the healthcare segment. While direct complaints include five advertisements, suo moto surveillance by ASCI, picked up 19 advertisements complained against. In personal care, a total of two advertisements complained against were direct complaints.

Twenty advertisements were complained against in the food and beverages segment. Direct Complaints were made against five advertisements while suo moto surveillance by ASCI picked 15 advertisements.

The Education segment drew a Total of 34 advertisements. Direct Complaints were made against four advertisements. Suo Moto Surveillance by ASCI picked 30 advertisements,

A total of nine advertisements were complained against in the others segment of which direct complaints were made against five advertisements and the rest were picked via Suo Moto Surveillance by ASCI.

DIRECT COMPLAINTS:
FOOD AND BEVERAGES:
Mobius Foundation/ Ayurvet Limited (Antibiotics in Chicken), All India Poultry Development and Service. Perfetti Van Melle India Pvt. Ltd (Chupa Chup Sour Strip and Sour Bite), Oshun Food Products Private Ltd (Native Milk), Nutravo Lifecare Pvt Ltd (Nutralyfe Garcinia Cambogia Herbs).

HEALTHCARE:
Jolly Healthcare (Jolly Vaseir), Shape in Slimming Centre, Aura Weight Loss Clinic, A R Ayurveda Pvt. Ltd (Ashwa Shakti powder), Greek Retail P. Limited (Refollium Capsules),

PERSONAL CARE:
The Himalaya Drug Company (Himalaya Youth Eternity under Eye Cream), The Promen.in (Promen Lip Lightener)

EDUCATION:
LegalEdge Tutorials, National Institute of Fire Safety Engineering (NIFSE), National Academy Of Fire and Safety Engineering (NAFS), Fortune Computer Academy

OTHERS:
Xiaomi Logistics, Magicon Impex Pvt Ltd (Jivi Mobiles), Yamaha Motor Pvt Ltd (Yamaha FZ), Walter Bushnell (Uriliser), Tata Steel Ltd (Tata Pipes)

SUO MOTO Surveillance by ASCI

FOOD BEVERAGE:-
Swad Food Products (Swad Adatt Matta Rice), Flipbald Health and Wellness Products (Flipbald De-addiction Powder), Flipbald Health and Wellness(Flipbald De-addiction Powder), Flipbald Health and Wellness (Flipbald Green Coffee Beans and Forme Oil), Flipbald Health and Wellness Products (Flipbald De-addiction Powder) Ganga Milk Foods (Ganga Shahi Kheer), Anil Foods (New Range of Millet Vermicellis), Super Salt Pvt Ltd (Top Line Activ Natural Salt), Super Salt Pvt Ltd (Top Line Activ Natural Salt), Super Salt Pvt Ltd (Top Line Activ Natural Salt), Bhopal Sahakari Dugdha Sangh (Sanchi Milk), Saboo Sodium Chloro Limited (Surya Salt), Paras Mushroom.

HEALTHCARE:-
Slim N Slender, Olivia Skin Hair Clinic, Sah Hospital, ILS Hospital, Ranjeet Goswami Memorial Homeopathic Hospital, Aesthetica Implant Clinics Dental, Rediscover Clinic, Lotus Slimming Centre Pvt Ltd (Figure First), Dr Paiwal Physiotherapy Clinic, D.S Research Centre, Kaya Komal Avleh, Naturoveda India Pvt Ltd Naturoveda Health World, Naturoveda India Pvt Ltd (Naturoveda Health World), Arogyam Ayurvedic Centre (Allergy Rakshak Range of Products, Ayurwin Pharma Private Limited (Nutrigain Plus Range of Products – Capsules Powder) Ayurwin Pharma Private Limited (Nutrigain Plus Range of Products – Capsules Powder) Flipbald Health Wellness (Flipbald De-addiction powder) Flipbald Health Wellness (Flipbald De-addiction powder), Flipbald Health Wellness (Flipbald De-addiction powder).

EDUCATION:-
Law Prep Tutorial, Winner Institute, Maharashtra Academy of Engineering and Educational Research Vishwashanti Gurukul, Sham Kaushalya Taneja Educational Society – Taneja Public School, Rao Edusolutions Pvt Ltd Rao IIT Academy, DAV College Managing Committee, International Institute of Fashion Design, Karnel Academy.

Complaints against advertisements of 22 educational institutes listed below are UPHELD mainly because of unsubstantiated claims and/ or misleading claims that they provide 100 per cent placement/ placement assistance and/ or they claim to be the No.1 in their respective fields.

X-EEED Coaching, Vinayak Classes, Saraswati Institute of Career Studies, Patliputra Coaching Classes, Pai Defence Academy, Nice Study Circle, Institute For Competitive Exam, Marwad Defence Academy, Bansal Classes Pvt Ltd, Deeksha College of Commerce, Institute of Account Management Studies – Institute of Accounts and Management Business School, Ayyappa Constable Coaching Center, The Sumana Foundation /School of Indian Hotel Management, Kautilya Academy, Brills Institute, Delhi Public School, A B Foundation, Safal Academy , Shrestha Samajik Seva Sansthan Samiti – Shrestha Private Ltd, Image Infotainment Ltd (Image Computer Education), Jagat Narain Romesh Chander Educational Trust (J.R. Media Institute), Excellent Civil Academy.

OTHERS:-
Confident Group (Confident Canopus), Maa Kamakhavya Darbar Fragrances India Pvt. Ltd (Tiranga Sacred Agarbatti), Jet Knitwear (Jet Lycot Readymades), ARG Outlier Media Asianet News Pvt Ltd Republicworld.com.

For feedback/comments, please write to newsteam@afaqs.com

First Published : July 27, 2018 06:51 AM